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Abstract
Background: Suicide is a global public health concern, but it is preventable. Increased contact with primary care before the
suicide or attempted suicide raises opportunities for intervention and prevention. However, suicide assessment and management
are areas that many general practitioners (GPs) find particularly challenging. Previous research has indicated significant variability
in how GPs understand, operationalize, and assess suicide risk, which subsequently has an impact on clinical decision making.
Clinical decision support systems (CDSS) have been widely implemented across different health care settings, including primary
care to support practitioners in clinical decision making. A CDSS may reduce inconsistencies in the identification, assessment,
and management of suicide risk by GPs by guiding them through the consultation and generating a risk assessment plan that can
be shared with a service user or with specialized mental health services.
Objective: Our aim is to co-develop and test with end users (eg, GPs, primary care attendees, mental health professionals) an
electronic clinical decision support system (e-CDSS) to support GPs in the identification, assessment, and management of
suicidality in primary care.
Methods: Ours is an ongoing embedded mixed-methods study with four phases: (1) qualitative interviews with GPs to explore
their views on the content, format, and use of the e-CDSS, as well as consultation with two service-user advisory groups (people
aged ≤25 and people aged ≥25) to inform the content of the e-CDSS including phrasing of items and clarity; (2) participatory
co-production workshops with GPs, service users, and clinical experts in suicidality to determine the content and format of the
e-CDDS; gain consensus of the relevance of items; establish content validity and identify pathways to implementation, using the
Consolidated Framework for Implementation Research; (3) building the e-CDSS so that it guides the GP through a consultation;
and (4) usability testing of the e-CDSS with GPs and service users in one primary care practice involving a nonlive and a live
stage.
Results: The study was funded for four years, to take place between 2015 and 2019, and is currently completing phase 4 data
collection. The first results are expected to be submitted for publication in June 2019. The findings will enable us to evaluate the
feasibility, acceptability, and usability of a suicide-specific, electronic, guided decision support system in primary care.
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Conclusions: This study will be the first to explore the feasibility, acceptability, and usability of an electronic, guided decision
support system for use in primary care consultations for the improved assessment and management of suicidality.
International Registered Report Identifier (IRRID): RR1-10.2196/11135
(JMIR Res Protoc 2018;7(12):e11135)  doi: 10.2196/11135
KEYWORDS
suicide; primary care; general practitioner; clinical decision support system
Introduction
Suicide is a global public health concern costing the lives of
over 800,000 people per year [1]. It is among the three leading
causes of death in those aged 15-44 and the second leading
cause of death among children and young people aged 15-29
[1]. Among the strongest risk factors for suicide are history of
suicide attempts, mental illness, and self-harm [2]. The
likelihood of suicide may be reduced where health professionals
and service users openly and compassionately identify and
collaboratively address suicide risk. Research shows increased
contact with health professionals and in particular, general
practitioners (GPs), in the months prior to a suicide or an
attempted suicide [3-5]. Contact rates range from 60%-83% in
the 12-month period before suicide [4-6], and 45% of those who
die by suicide are likely to have had contact with a primary care
provider within 4 weeks of suicide [3]. Primary care is often
both the first and last health care contact for those who take
their life [7]. These high rates of pre-suicide contact suggest
that primary care services are well placed to identify early,
assess, and mitigate risk of suicide. Primary care is, therefore,
considered an appropriate context to develop suicide prevention
initiatives [8].
Suicide risk assessment and management, however, is an area
that most GPs find particularly challenging, despite being a
common feature of their work. In a typical morning or afternoon
primary care surgery in the United Kingdom, at least one new
case of depression out of 20 patients requires suicide risk
assessment [9]. Organizational barriers including time
constraints and a heavy workload coupled with a lack of
specialist clinical skills and insufficient mental health training
have been identified by GPs as significant barriers to the
assessment and management of suicidal presentations [10-12].
A recent study by Michail et al [11] has identified significant
variability in how GPs understand and operationalize risk, which
subsequently has an impact on clinical decision making. GPs
may be more likely to inquire about suicide risk following
recognition of clinical features associated with depression,
psychosis, or long-term physical health problems [13], yet
evidence shows that depression is not systematically detected
and managed by GPs [14,15]. This variability in clinical
decision-making processes may be because practitioners tend
to develop “mindlines” or heuristics linking certain risk factors
with eventual outcomes [16,17]. Such cognitive devices may
be developed by practitioners to aid information gathering and
clinical decision making in time-pressured contexts.
Heuristic-based decision making enables a rapid
problem-solving approach to fast track a diagnosis or clinical
decision; this is sometimes referred to as a “pattern matching”
approach to clinical reasoning [18]. However, these cognitive
shortcuts employed by practitioners could prove to be
problematic. If allowed to become automatic and unconscious,
they could lead to misdiagnosis and poor patient experience
[19]. Heuristics and “gut-hunches” may play an important role
in determining when clinicians inquire about suicide risk and
influencing situations where practitioners fail to identify suicide
potential [20].
Clinical decision support systems (CDSS) are “any electronic
system designed to aid directly in clinical decision making, in
which characteristics of individual patients are used to generate
patient specific assessments or recommendations that are then
presented to clinicians for consideration” [21]. A recent
systematic review identified three categories of CDSS used
across different health care settings, including primary care
[22]. These include decision prompts, information retrieval
systems, and bibliographic databases. All three types of CDSS
have been shown to be positively associated with improved
health care delivery including enhanced clinical decision
making, supporting accurate diagnosis, and improving standards
of chronic disease management and preventative care [22]. One
of the added benefits of CDSS software is the “cognitive forcing
function,” which may temporarily prompt the GP to switch from
heuristic based to analytical decision making [23].
A suicide-specific electronic CDSS (e-CDSS) could address
some of the aforementioned barriers to suicide assessment and
management in primary care [11] by guiding GPs through the
clinical risk assessment at the time of the consultation. Although
there are several evidence-based suicide prevention training
programs, for example, Applied Suicide Intervention Skills
Training, and Skills-Based Training On Risk Management
(STORM) for suicide prevention demonstrating sustained
improvements in knowledge, skills, and attitudes [23-26], these
do not address the challenges to assessment and management
of suicidality in primary care, such as lack of guidance during
the consultation and support in clinical decision making [11].
Suicide prevention training programs for GPs specifically have
produced ambiguous results as many of these are provided to
health professionals at population levels, rather than targeting
GPs at their work place in primary care [27].
On the contrary, a suicide-specific e-CDSS could provide a
standardized method of recording risk history and flagging
ongoing social circumstances or risk factors [11], thus,
facilitating appropriate management options. Most importantly,
it could save the GP work and time by generating a risk
assessment and management plan that can be shared with a
service user and carer(s) or with specialized mental health
services. Emerging evidence suggests that technology-based
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suicide prevention developments can assist clinicians with the
identification and management of suicide risk, by providing
clinical decision support [28]. However, this is still an
underexplored area.
The aim of this study is to co-develop and test with end users
(eg, GPs, primary care attendees, mental health professionals)
an e-CDSS to support GPs in the identification, assessment,
and management of suicidality in primary care.
Methods
Design
This is an embedded mixed-methods study incorporating a
quantitative strand within a broader qualitative design (Figure
1). This design allows for bringing together insights from the
different stages of the study to give a comprehensive approach
to content development and initial evaluation of the e-CDSS in
practices. The study will take place in the East Midlands, United
Kingdom, between September 2017 and February 2019. The
study received ethics approval by East Midlands - Nottingham
1 Research Ethics Committee (17/EM/0317).
Sample and Recruitment
Phase 1
Qualitative Interviews With General Practitioners
GPs working in National Health Services (NHS) primary care
practices across the East Midlands will be invited to take part
in an individual face-to-face qualitative, semistructured,
audiotaped interview with one researcher (MH) to explore their
experiences of assessing suicide risk in primary care as well as
their clinical reasoning and decision making about risk
management. The interviews will also explore GPs’ views on
the content, format, and use of the e-CDSS during consultation
with at-risk individuals.
For Phase 1, up to 30 GPs will be recruited from primary care
practices across the East Midlands region. The GP cluster leads,
the mental health lead, GPs, or mental health commissioners
across the various clinical commissioning groups in East
Midlands will be initially approached to discuss the study and
recruitment procedure. An invitation letter will be cascaded by
email to all GPs by either the mental health lead
GPs/commissioners or cluster leads, to inform potential
participants about the study and encourage them to participate.
Interviews with GPs will take place at times and locations
convenient to them. For Phase 2, a purposive sample of GPs
(ie, age, gender, ethnicity, and years of experience) will be
drawn from Phase 1 and invited to attend the co-production
workshops.
Service-User Advisory Group
To inform the development and design of the e-CDSS, two
service-user advisory groups (SUAG) (people aged ≤25 and
people aged ≥25) will be convened and meet (separately) four
times between March 2018 and September 2018. The aim of
this consultation would be to discuss potential items for
inclusion in the e-CDSS, including phrasing and clarity, and to
gauge the advisory groups’ view of whether proposed items
might facilitate further disclosure or hinder concealment of
suicide-related information.
For Phase 1, up to 10 participants aged 14-65 registered with a
GP in Nottingham City or Nottinghamshire County will be
recruited from various sources. These include primary care
practices, third sector organizations, charities, self-help groups,
existing public and patient involvement networks (eg,
Collaboration for Leadership in Applied Health Research and
Care [East Midlands] Patient and Public Involvement work
stream), and social media. Participants would have to have a
history of being through a GP consultation where suicidal
thoughts, feelings, or behaviors had been discussed. For young
people under the age of 16, participation is conditional on
parental/guardian consent. For Phase 2, a purposive sample of
service users (eg, age, gender, ethnicity) will be drawn from
Phase 1 and invited to attend the co-production workshops.
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Figure 1. Study research design. e-CDSS: electronic clinical decision support; GP: general practitioner.
Phase 2
Co-Production Workshops
A group of experts and health care professionals including GPs
and service users from Phase 1 (drawn based on age, gender,
and ethnicity) as well as clinical experts in suicidality will be
invited to attend three half-day participatory co-production
workshops. In the first co-production workshop, the research
team will present the expert group with a list of questions and
prompts extracted from (1) previously published assessment
scales for suicide and self-harm, and (2) GP data during Phase
1, for inclusion in the e-CDSS. Using a modified Delphi
approach, the expert group will individually rank these items
according to their perceived relevance for assessment of
self-harm and suicidality using a 4-point Likert scale (1=not
relevant, 2=somewhat relevant, 3=quite relevant, 4=highly
relevant). A prespecified consensus margin (≥65%-70%) used
by previous similar studies [29] will be used to determine
inclusion of items in the e-CDSS. In the second co-production
workshop, the research team will redistribute those items within
the prespecified consensus margin and ask participants to rank
these items again according to their perceived relevance for
assessment of self-harm and suicidality using the same 4-point
Likert scale. After finalizing the items for inclusion in the
e-CDSS, participants will be asked to complete the Content
Validity Index (CVI) questionnaire to establish content validity
(>0.80) [30]. This will then be followed by group discussion to
reaffirm the face and content validity of the final items and to
gain endorsement of items for inclusion in the prototype
e-CDSS. This reconciliation of the data-driven methodological
approach with the situated knowledge and perspective of GPs,
people with lived experience, and suicide prevention experts is
important to ensure goodness of fit of the prototype with end
users and within the primary care context. The aim of the third
co-production workshop would be to identify pathways to
implementation as well as barriers and facilitators of adopting
the e-CDSS in routine practice, using the Consolidated
Framework for Implementation Research [31]. The aim would
be to create a “change map,” that is, a graphical depiction of
the pathway to long-term implementation of the e-CDSS.
Phase 3
Building the e-CDSS
Findings from Phase 1 and 2 will inform the most appropriate
solution for an e-CDSS. The tool will be built by PRIMIS, a
business unit of the University of Nottingham that specializes
in building software to interface with and interrogate primary
care information systems [32]. The tool will use clinical and
informatics expertise alongside stakeholder requirements to
present an option appraisal for a solution. Where possible,
solutions will be based on existing Clinical Terms and Read
Codes (ie, mandatory clinical coding systems for GP information
technology systems). PRIMIS will account for current GP
recording practices and the results of previous literature reviews
in the field. A prototype of the tool will be developed in either
The Phoenix Partnership (TPP) SystmOne or Egton Medical
Information System (EMIS Web). The tool will take the form
of a clinical system “protocol” (decision support algorithm) that
will be response driven, that is, entries to the protocol will guide
the user to the next appropriate stage.
Phase 4
Usability Testing of e-CDSS
An iterative evaluation of the e-CDSS prototype over a 6-month
period will be conducted using an established theoretical and
methodological framework [33] to refine the content of the final
prototype, assess its usability, and provide the basis for initial
evaluation of the e-CDSS in practice. The usability testing will
be carried out in one primary care practice, and all GPs within
this practice will be invited to participate. Usability testing will
involve a nonlive and a live stage. Nonlive testing will involve
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GPs entering data into the e-CDSS in relation to simulated
suicidal consultations based on clinical vignettes and completing
a think-aloud exercise (“cognitive walk-through”) in which they
will be asked to describe possible next questions and lines of
inquiry following on from prompts and items within the
e-CDSS. GPs will be asked to complete a brief evaluation
questionnaire (System Usability Scale [SUS]) [34] relating to
the usability and function of the e-CDSS. Following “go-live”
of the system, GPs will be asked to use the prototype e-CDSS
during live patient consultations if and when appropriate (eg,
during scheduled mental health clinics). Following the use of
the e-CDSS, GPs will be asked to complete the SUS as well as
a short survey questionnaire about the overall relevance of the
e-CDSS to suicidal consultations, its impact on clinical decision
and management, its impact on workflow, as well as adoption
and acceptability.
Usability testing will take place in one practice (Nottingham
City or Nottinghamshire County), and all GPs employed within
the practice will be eligible to participate. The recruitment of
the practice will be based on convenience sampling based on
accessibility and expressions of interest.
At this stage, the study will not be seeking feedback from
primary care service users who have been in a consultation
where the prototype e-CDSS is used, since the aim of the current
study is to design the content for and to build an e-CDSS to
support GPs in the identification, assessment, and management
of suicidality in primary care. The current study will seek to
investigate the compatibility of the e-CDSS with GPs’
consultation styles, the impact and integration into GP workflow,
and its acceptability and feasibility to GPs. Further research is
planned to formally investigate service user satisfaction within
consultations in which the tool is used.
Feasibility, Usability, and Acceptability Criteria for Success
for the e-CDSS
A set of predetermined criteria, in line with previous studies
[35,36], will be used to assess feasibility, usability, and
acceptability of the e-CDSS (Table 1). These criteria will be
measured using data from co-production workshops (Phase 2),
as well as the SUS and the survey questionnaire data GPs
provide during usability testing (Phase 4). If the e-CDSS
prototype does not reach the criteria for success, it will be
refined according to the users’ needs and retested by GPs until
it is fully adapted to their requirements.
Table 1. Electronic clinical decision support (e-CDSS) feasibility, usability, and acceptability criteria for success.
Study phaseCriteriaMeasure
Phase 2: Co-production workshops>0.80 on the Content Validity InventoryContent validity
Phase 4: Usability testing (nonlive and
live stage)
≥70 on the System Usability ScaleUsability
Phase 4: Survey questionnaire (free-text
response plus Likert Scales)
Frequency of use—evidence that the e-CDSS is used by general practitioners
at least once in a surgery with any new patient with depression, or new or
severe mental health problems
Adoption/Acceptance
Phase 4: Survey questionnaire (free-text
response plus Likert Scales)
GP reports and feedback on satisfaction with the e-CDSS; perceived barriers;
ideas for improvement; ideas for further utilization; impact on workflow;
impact on content of consultation; and impact of management (eg, referral
rates, prescription rates)
Feasibility and relevance in
practice
Measures
Content Validity Index
The Content Validity Index (CVI) [30] is a widely used method
of quantifying content validity for questionnaires with multiple
items [30]. The CVI captures interrater agreement, through a
standardized approach to computing agreement for each
proposed item for inclusion in the questionnaire (or in this case
the e-CDSS), as well as for the overall questionnaire.
Participants are asked to rate each proposed item on an ordinal
scale from 1=not relevant to 4=highly relevant. For each item,
the number of ratings assigning 3 or 4 is then divided by the
number of respondents to provide the proportion agreeing on
the relevance of the item. The average score across each item
of the e-CDSS will then also be calculated to generate a global
content validity score. Scores of 0.80 are often considered the
lower acceptable limits [30]. Application of the CVI will allow
quantification of interrater agreement and be followed by group
discussion to finalize the items for inclusion in the e-CDSS.
System Usability Scale
The SUS [34] will be administered to GPs during Phase 4 to
measure the usability of the e-CDSS. This has been used
extensively to assess the usability of a wide range of products
and services including hardware and software, mobile devices,
websites, and apps [37]. The SUS comprises 10 statements rated
on a 5-point Likert scale (strongly agree to strongly disagree),
recording respondents’ views of the usability of the e-CDSS.
Total scores for the SUS range from 0-100. Published guidance
[37] suggests that products with adequate usability will score
above ≥70.
Survey Questionnaire
A short survey questionnaire for completion by GPs at Phase
4 will be developed based on data from GP interviews and
SUAG meetings (Phase 1) as well as relevant literature [11] to
assess the overall relevance of the e-CDSS to consultations in
relation to suicide presentations, its impact on workflow,
adoption, and acceptance as well as its impact on the content
of the consultation and clinical outcomes (eg, referral and
prescription rates). The survey questionnaire will use a
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combination of Likert scales and free-text response. Quantitative
items will be calculated to provide total scores, mean scores,
and variance scores for each item across participants to provide
an indication of acceptability of the e-CDSS to GPs in relation
to clinical appropriateness, contextual appropriateness, and
quality of actionable decision support. High variance might be
seen for some items where practices vary a lot in context and
less so on other items.
Data Analysis
Phase 1
GP qualitative interviews will be audio recorded and fully
transcribed removing any identifiable data to preserve participant
anonymity. Data will be analyzed using thematic [38] and
content analysis [39]. Thematic analysis will allow the
examination and recording of themes (patterns) within the GP
data in relation to challenges in assessing and managing suicide
risk in primary care, barriers and drivers for the use of the
e-CDSS, and potential items and prompts for inclusion in the
e-CDSS. Content analysis will be used to provide frequencies
of coded themes including frequencies of those items and
prompts mentioned by GPs during the interviews. NVivo 11
software [40] will be used to facilitate data analysis. Field notes
kept during the SUAG group meetings will be presented in
narrative form [41].
Phase 2
Statistical analysis will be descriptive (IBM SPSS 24.0).
Consensus agreement will be calculated using counts (n) and
proportions (%) for a median relevance rating of ≥3.25.
Regarding the CVI, for each item the number of ratings
assigning 3 or 4 will be divided by the number of respondents
to provide the proportion agreeing with the relevance of the
item. The average score across each item of the e-CDSS will
then be calculated to generate a global content validity score.
Scores of >0.80 are considered acceptable [30].
Phase 4
Consent, recruitment, and retention rates of GPs participating
in the usability testing will be calculated. SUS item scores will
be summed to obtain total scores. Total scores of ≥70 indicate
adequate usability [37]. For the survey questionnaire assessing
adoption, acceptability, relevance, and impact on management
and workflow, we will present the mean, variance or standard
deviations, and 95% confidence intervals for normally
distributed variables, the median and interquartile range for
skewed variables, and the frequency and proportion for
categorical variables.
Results
The study was funded for 4 years, to take place between 2015
and 2019, and is currently completing phase 4 data collection.
Enrollment to Phase 1 (GP interviews) was completed in May
2018, with 30 GPs interviewed, and 6 people with lived
experience taking part in SUAGs. Phase 2 (co-production
workshops) was completed in June 2018, with a total of 24
participants taking part (ie, GPs, service users, commissioners,
mental health clinicians, and subject matter experts in suicide
prevention). Phase 3 (building the e-CDSS is currently
underway) and Phase 4 (usability testing of the e-CDSS) is
scheduled to take place between autumn 2018 and early 2019.
Data analysis will be ongoing throughout Phase 4, with the first
results expected to be submitted for publication in June 2019.
Discussion
Principal Considerations
Suicide is a major public health issue, but it is preventable. As
the majority of pre-suicide contact takes place in primary care,
GPs have an increasingly important role in the early
identification, assessment, and management of suicide risk. This
research will lead to the development of an evidence-based,
electronic, guided decision support tool for use in primary care
for the improved assessment and management of suicidality.
The end product will be the output of collaboration and
co-production between the research team, health informatics
experts, and key stakeholders including primary care
practitioners and service users. This collaborative approach will
facilitate the implementation and uptake of the tool, which is a
potential gain of this research. In addition, this research is
expected to raise awareness, improve education of GPs about
suicide, and promote best practice in assessing and managing
risk. If the feasibility, acceptability, and usability of the e-CDSS
are established in this study, then further research would be
needed to establish its effectiveness and efficiency in routine
primary care consultations. A pilot, cluster (practice level)
randomized controlled trial of e-CDSS versus usual care would
examine whether the use of e-CDSS leads to improved skills
and capacity of GPs to manage suicidal behavior. The primary
outcome would be assessed using the Suicide Intervention
Response Inventory-2 [42] at baseline, postintervention, and 6
months follow-up. Secondary outcomes would include
self-reported preparedness measures [43]; GPs’ attitudes
(Attitudes Towards Suicide [44]) and confidence (using the
5-item STORM confidence in the assessment and management
of suicidal people scale) [24]; service user satisfaction using
qualitative interviews; and cost-effectiveness. If the effectiveness
and cost-effectiveness of the e-CDSS is established, then this
research could lead to improved assessment and management
of suicidality in primary care and better patient experience of
primary care mental health services.
Conclusions
This study will be the first to explore the feasibility,
acceptability, and usability of an electronic, guided decision
support system for use in primary care consultations for the
improved assessment and management of suicidality. A CDSS
may reduce inconsistencies in the identification, assessment,
and management of suicide risk by GPs by guiding them through
the consultation and generating a risk assessment plan that can
be shared with a service user or with specialized mental health
services.
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